Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1985 Nov;22(5):854–855. doi: 10.1128/jcm.22.5.854-855.1985

Cephalothin susceptibility as a potential marker for the Aeromonas sobria group.

J M Janda, M R Motyl
PMCID: PMC268542  PMID: 4056009

Abstract

Fifty-four motile Aeromonas strains, composing the three currently recognizable species, were tested for susceptibility to cephalothin by broth dilution and disk agar diffusion assays. Cephalothin susceptibility was significantly associated with Aeromonas sobria (P less than 0.001) and may be an additional phenotypic marker useful in the identification of this species.

Full text

PDF
854

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
  2. Daily O. P., Joseph S. W., Coolbaugh J. C., Walker R. I., Merrell B. R., Rollins D. M., Seidler R. J., Colwell R. R., Lissner C. R. Association of Aeromonas sobria with human infection. J Clin Microbiol. 1981 Apr;13(4):769–777. doi: 10.1128/jcm.13.4.769-777.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Janda J. M. Biochemical and exoenzymatic properties of Aeromonas species. Diagn Microbiol Infect Dis. 1985 May;3(3):223–232. doi: 10.1016/0732-8893(85)90034-3. [DOI] [PubMed] [Google Scholar]
  4. Janda J. M., Bottone E. J., Reitano M. Aeromonas species in clinical microbiology: significance, epidemiology, and speciation. Diagn Microbiol Infect Dis. 1983 Sep;1(3):221–228. doi: 10.1016/0732-8893(83)90021-4. [DOI] [PubMed] [Google Scholar]
  5. Janda J. M., Reitano M., Bottone E. J. Biotyping of Aeromonas isolates as a correlate to delineating a species-associated disease spectrum. J Clin Microbiol. 1984 Jan;19(1):44–47. doi: 10.1128/jcm.19.1.44-47.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Joseph S. W., Daily O. P., Hunt W. S., Seidler R. J., Allen D. A., Colwell R. R. Aeromonas primary wound infection of a diver in polluted waters. J Clin Microbiol. 1979 Jul;10(1):46–49. doi: 10.1128/jcm.10.1.46-49.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lee J. V., Shread P., Furniss A. L., Bryant T. N. Taxonomy and description of Vibrio fluvialis sp. nov. (synonym group F vibrios, group EF6). J Appl Bacteriol. 1981 Feb;50(1):73–94. doi: 10.1111/j.1365-2672.1981.tb00873.x. [DOI] [PubMed] [Google Scholar]
  8. Motyl M. R., McKinley G., Janda J. M. In vitro susceptibilities of Aeromonas hydrophila, Aeromonas sobria, and Aeromonas caviae to 22 antimicrobial agents. Antimicrob Agents Chemother. 1985 Jul;28(1):151–153. doi: 10.1128/aac.28.1.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Popoff M., Véron M. A taxonomic study of the Aeromonas hydrophila-Aeromonas punctata group. J Gen Microbiol. 1976 May;94(1):11–22. doi: 10.1099/00221287-94-1-11. [DOI] [PubMed] [Google Scholar]
  10. Shaw D. H., Hodder H. J. Lipopolysaccharides of the motile aeromonads; core oligosaccharide analysis as an aid to taxonomic classification. Can J Microbiol. 1978 Jul;24(7):864–868. doi: 10.1139/m78-143. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES